Ascendis Pharma A (ASND) EPS (Diluted) Growth (5y) (2019 - 2026)
Ascendis Pharma A (ASND) EPS (Diluted) Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ascendis Pharma A | 15.35 Bn | 14.68 Bn | 268.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.73% |
| Dec 31, 2025 | 49.57% |
| Sep 30, 2025 | 18.83% |
| Jun 30, 2025 | -17.96% |
| Mar 31, 2025 | -24.48% |
| Dec 31, 2024 | 40.34% |
| Sep 30, 2024 | -36.98% |
| Jun 30, 2024 | 3.83% |
| Mar 31, 2024 | 34.09% |
| Dec 31, 2023 | -21.11% |
| Sep 30, 2023 | -34.91% |
| Jun 30, 2023 | 47.18% |
| Mar 31, 2023 | -13.75% |
| Dec 31, 2022 | -33.53% |
| Sep 30, 2022 | -27.69% |
| Jun 30, 2022 | -15.15% |
| Mar 31, 2022 | -32.57% |
| Dec 31, 2021 | -34.61% |
| Sep 30, 2021 | 36.93% |
| Jun 30, 2021 | 53.48% |